Centene Corp. (NYSE:CNC) is one of the most oversold S&P 500 stocks so far in 2025. On July 2, Centene’s share price plunged ...

Centene fell by 11.1 percent week-on-week, from $31.44 on July 11 to $27.95 last Friday—a new all-time low, as investors turned cautious ahead of its second quarter earnings results, further ...

Tesla expected to post double-digit declines in earnings, sales. Fed chief Powell speech in focus as central bank ...

U.S. stocks advanced on Thursday as strong corporate earnings and upbeat economic data boosted market sentiment. PepsiCo and ...

Tariff risk remains alive: Bloomberg reports Trump is considering 10–15% tariffs on 150+ countries, mainly smaller trade partners. Meanwhile, the EU is preparing retaliatory tariffs on U.S. goods and ...

Centene Withdraws Earnings Forecast, Triggering Possible Credit Downgrade S&P Global Ratings is considering whether to reclassify Centene Corp.'s credit ratings to junk, which would strongly impact ...

Molina's shares drop amid earnings warnings, Medicaid cuts, and cost pressures. Click here to read more about MOH stock and ...

With a market cap of $16.6 billion, Centene Corporation (CNC) is a multinational healthcare enterprise that delivers services primarily to under-insured and uninsured populations through ...

Centene is set to announce its second-quarter results later this month, and analysts anticipate double-digit earnings drop.

The 25% decline in Centene’s stock seems warranted given the substantial earnings adjustment and ongoing ambiguity.